Search research articles
Contact Us
Filters
Showing results (141-150 of 219) with videos related to
Page
of 22
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2024
Oxidized Low-Density Lipoprotein Induces Reactive Oxygen Species-Dependent Proliferation of Intestinal Epithelial Cells
Eddy E Gonzalez-Horta, Juan F Burgueno, María J Leiva, et al.
Journal of Crohn'S & Colitis
|
February 4, 2024
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis
Subrata Ghosh, Brian G Feagan, Elyssa Ott, et al.
The American Journal of Gastroenterology
|
May 19, 2023
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission
Andres J Yarur, Maria T Abreu, Parakkal Deepak, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 11, 2022
Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial
Silvio Danese, Bruce E Sands, Maria T Abreu, et al.
The American Journal of Gastroenterology
|
October 11, 2008
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial
James F Marion, Jerome D Waye, Daniel H Present, et al.
Digestive Diseases and Sciences
|
July 9, 2018
Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease
Oriana M Damas, Derek Estes, Danny Avalos, et al.
Journal of Crohn'S & Colitis
|
May 3, 2024
Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme
Miguel Regueiro, Britta Siegmund, Andres J Yarur, et al.
The American Journal of Gastroenterology
|
August 13, 2021
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
Adam S Cheifetz, Maria T Abreu, Waqqas Afif, et al.
Gastroenterology
|
February 6, 2004
Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease
William S Mow, Eric A Vasiliauskas, Ying-Chao Lin, et al.
Inflammatory Bowel Diseases
|
June 20, 2024
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program
Vipul Jairath, David T Rubin, Bram Verstockt, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 219) with videos related to
Sort By:
Page
of 22
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2024
Oxidized Low-Density Lipoprotein Induces Reactive Oxygen Species-Dependent Proliferation of Intestinal Epithelial Cells
Eddy E Gonzalez-Horta, Juan F Burgueno, María J Leiva, et al.
Journal of Crohn'S & Colitis
|
February 4, 2024
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis
Subrata Ghosh, Brian G Feagan, Elyssa Ott, et al.
The American Journal of Gastroenterology
|
May 19, 2023
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission
Andres J Yarur, Maria T Abreu, Parakkal Deepak, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 11, 2022
Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial
Silvio Danese, Bruce E Sands, Maria T Abreu, et al.
The American Journal of Gastroenterology
|
October 11, 2008
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial
James F Marion, Jerome D Waye, Daniel H Present, et al.
Digestive Diseases and Sciences
|
July 9, 2018
Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease
Oriana M Damas, Derek Estes, Danny Avalos, et al.
Journal of Crohn'S & Colitis
|
May 3, 2024
Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme
Miguel Regueiro, Britta Siegmund, Andres J Yarur, et al.
The American Journal of Gastroenterology
|
August 13, 2021
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
Adam S Cheifetz, Maria T Abreu, Waqqas Afif, et al.
Gastroenterology
|
February 6, 2004
Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease
William S Mow, Eric A Vasiliauskas, Ying-Chao Lin, et al.
Inflammatory Bowel Diseases
|
June 20, 2024
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program
Vipul Jairath, David T Rubin, Bram Verstockt, et al.
Page
of 22